Form 4: Gevo COO Sells 100,000 Shares Under 10b5-1 Plan
Insider Trading Report
Gevo's President & COO, Christopher Michael Ryan, sold 100,000 shares of common stock for approximately $2.82 per share under a pre-arranged trading plan.
Summary
- Christopher Michael Ryan, President & COO of Gevo, Inc. (GEVO), reported the sale of 100,000 shares of common stock.
- The transaction occurred on October 15, 2025, at a weighted average price of $2.8187 per share.
- The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2024.
- The reported sale price ranged from $2.75 to $2.89 per share.
- Following this transaction, Ryan directly owns 1,531,938 shares of Gevo common stock.
- An additional 22,008.08 shares are indirectly owned through a 401(k) plan.
- Between September 4, 2025, and October 15, 2025, 8.60 shares were disposed of from the 401(k) plan to cover administrative fees.
Sentiment
Score: 4
Explanation: The sale of a significant number of shares by a high-ranking executive, even if pre-planned, can be perceived as a slightly negative signal by the market. However, the existence of a 10b5-1 plan mitigates the perception of opportunistic trading.
Negatives
- President & COO Christopher Michael Ryan sold 100,000 shares of common stock, which can be perceived as a negative signal by investors, despite being pre-planned.
Future Outlook
NA
Industry Context
This filing reports a routine insider transaction and does not provide information directly related to broader industry trends or competitive landscape for Gevo, Inc.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Adoption | The reported sales were executed under a Rule 10b5-1 trading plan, adopted on November 26, 2024, which demonstrates pre-planned insider transactions and adherence to SEC guidelines for insider trading. | 11/26/2024 | Enhances transparency and reduces the perception of opportunistic insider trading, aligning with good corporate governance practices. |
Stakeholder Impact
- Shareholders may view the insider sale as a potential negative signal regarding the company's near-term prospects, although the pre-planned nature under Rule 10b5-1 provides some context.
Key Dates
| Date | Description |
|---|---|
| 11/26/2024 | Date Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 09/04/2025 | Start date of the period during which 8.60 shares were disposed of from the 401(k) plan. |
| 09/25/2025 | Date of the 401(k) plan statement used for reporting indirect ownership. |
| 10/15/2025 | Date of the reported common stock transaction. |
Recommendation
holdThe filing reports a pre-planned insider sale by a key executive. While insider selling can sometimes be a negative signal, the transaction was executed under a Rule 10b5-1 plan, indicating it was not based on immediate, non-public information. This single transaction, without additional context or company-specific news, typically warrants a 'hold' recommendation as it's a data point to monitor rather than a definitive indicator for a strong buy or sell.
Keywords
Gevo, GEVO, insider trading, Form 4, stock sale, 10b5-1 plan, Christopher Michael Ryan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.